Untitled

Wyss Institute Search Site

Technologies 4

NanoRx: Mechanically-Activated Drug Targeting
The Wyss team has developed a novel drug targeting nanotechnology that is activated locally by mechanical forces, either endogenous high shear stresses in blood created by vascular occlusion or mechanical energy applied locally using low-energy ultrasound radiation. Today, vascular blockage is the leading cause of death and disability in United States and Europe. Current therapies...
Microfluidic Hemostasis Monitor
The body’s ability to stop bleeding, also known as hemostasis, is critical for survival. For patients with blood clotting disorders, medical conditions requiring the use of anticoagulation or antiplatelet drugs, or who require treatment with extracorporeal devices that circulate their blood outside of the body, it is essential that care providers can rapidly monitor their...
Soft Exosuits for Lower Extremity Mobility
Our lower-extremity soft exosuit is made of light, flexible fabrics that move with the wearer like clothing, and apply precisely timed assistive forces to a patient's ankles to improve their walking and mobility. This technology was licensed by ReWalk Robotics, which has commercialized it as the ReStore™ for stroke rehabilitation.
EmuLAAte: Device-Based Stroke Prevention
Prefabricated, “one-size-fits-all” medical implants fail to match individual anatomies and can result in tissue damage and impaired healing. To address this concern, we’re pioneering transcatheter technology to create custom implants directly inside patients, tailored to their unique anatomy, to provide safer and more effective treatments across various medical conditions. As a first application, we are...

News 22

Multimedia 21